Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Mar;32(3):331–336. doi: 10.1128/aac.32.3.331

In vitro and in vivo Phlebovirus inhibition by ribavirin.

R W Sidwell 1, J H Huffman 1, B B Barnett 1, D Y Pifat 1
PMCID: PMC172170  PMID: 3129991

Abstract

Ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) was markedly inhibitory in vitro to Adames and Balliet strains of Punta Toro virus (PTV), a Phlebovirus related to Rift Valley fever and sandfly fever viruses. By using inhibition of viral cytopathic effect in LLC-MK2 cells with both virus strains, the 50% effective dose was 4 to 10 micrograms/ml and the virus rating was 1.3. The Adames strain of PTV infection in mice was established for evaluation of the in vivo antiviral efficacy of ribavirin. The drug was administered subcutaneously (s.c.) twice daily for 5 to 7 days beginning 4 h pre-virus inoculation, 24 h post-virus inoculation, or 36 h post-virus inoculation, with increased survivors, reduced hepatic icterus, reduction of serum glutamic oxalic acid transaminase and serum glutamic pyruvic acid transaminase, and inhibition of infectious virus from sera and livers of infected mice. The minimum effective dose was 4.7 mg/kg per day, with a maximum tolerated dose of 75 mg/kg per day. When the same treatment schedule beginning 4 h pre-virus inoculation, 4 h post-virus inoculation, or 24 h post-virus inoculation was used, orally administered ribavirin was effective at doses as low as 6.3 mg/kg per day. Single s.c. ribavirin treatments at doses of 175 to 700 mg/kg administered from 4 to 48 h post-virus inoculation were also effective. No effect was seen when ribavirin was administered s.c. to mice infected intracerebrally with the PTV strain Balliet, even though treatment was begun 36 h before virus exposure.

Full text

PDF
331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ferrara E. A., Oishi J. S., Wannemacher R. W., Jr, Stephen E. L. Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys. Antimicrob Agents Chemother. 1981 Jun;19(6):1042–1049. doi: 10.1128/aac.19.6.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Goswami B. B., Borek E., Sharma O. K., Fujitaki J., Smith R. A. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem Biophys Res Commun. 1979 Aug 13;89(3):830–836. doi: 10.1016/0006-291x(79)91853-9. [DOI] [PubMed] [Google Scholar]
  3. Huffman J. H., Sidwell R. W., Khare G. P., Witkowski J. T., Allen L. B., Robins R. K. In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother. 1973 Feb;3(2):235–241. doi: 10.1128/aac.3.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. MCCLOSKEY R. V., SHELOKOV A. FURTHER CHARACTERIZATION AND SEROLOGICAL IDENTIFICATION OF CHAGRES VIRUS, A NEW HUMAN ISOLATE. Am J Trop Med Hyg. 1965 Jan;14:152–155. doi: 10.4269/ajtmh.1965.14.152. [DOI] [PubMed] [Google Scholar]
  5. Maar S. A., Swanepoel R., Gelfand M. Rift Valley fever encephalitis. A description of a case. Cent Afr J Med. 1979 Jan;25(1):8–11. [PubMed] [Google Scholar]
  6. Punta Toro (PT) strain. D 4021A. Am J Trop Med Hyg. 1970 Nov;19(6 Suppl):1103–1104. [PubMed] [Google Scholar]
  7. Sidwell R. W., Allen L. B., Huffman J. H., Witkowski J. T., Sinon L. N. Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice. Proc Soc Exp Biol Med. 1975 Mar;148(3):854–858. doi: 10.3181/00379727-148-38647. [DOI] [PubMed] [Google Scholar]
  8. Sidwell R. W., Allen L. B., Khare G. P., Huffman J. H., Witkowski J. T., Simon L. N., Robins R. K. Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals. Antimicrob Agents Chemother. 1973 Feb;3(2):242–246. doi: 10.1128/aac.3.2.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sidwell R. W., Huffman J. H., Campbell N., Allen L. B. Effect of ribavirin on viral hepatitis in laboratory animals. Ann N Y Acad Sci. 1977 Mar 4;284:239–246. doi: 10.1111/j.1749-6632.1977.tb21956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sidwell R. W., Huffman J. H., Khare G. P., Allen L. B., Witkowski J. T., Robins R. K. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 1972 Aug 25;177(4050):705–706. doi: 10.1126/science.177.4050.705. [DOI] [PubMed] [Google Scholar]
  11. Sidwell R. W., Huffman J. H. Use of disposable micro tissue culture plates for antiviral and interferon induction studies. Appl Microbiol. 1971 Nov;22(5):797–801. doi: 10.1128/am.22.5.797-801.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Smith R. A., Sidwell R. W., Robins R. K. Antiviral mechanisms of action. Annu Rev Pharmacol Toxicol. 1980;20:259–284. doi: 10.1146/annurev.pa.20.040180.001355. [DOI] [PubMed] [Google Scholar]
  13. Srihongse S., Johnson C. M. Human infections with Chagres virus in Panama. Am J Trop Med Hyg. 1974 Jul;23(4):690–693. doi: 10.4269/ajtmh.1974.23.690. [DOI] [PubMed] [Google Scholar]
  14. Travassos da Rosa A. P., Tesh R. B., Pinheiro F. P., Travassos da Rosa J. F., Peterson N. E. Characterization of eight new phlebotomus fever serogroup arboviruses (Bunyaviridae: Phlebovirus) from the Amazon region of Brazil. Am J Trop Med Hyg. 1983 Sep;32(5):1164–1171. doi: 10.4269/ajtmh.1983.32.1164. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES